Basilea Pharmaceutica AG BSLN.SW
BSLN.SW
Basilea Pharmaceutica AG IDIA.SW
Idorsia Ltd NWRN.SW
Newron Pharmaceuticals S.p.A. MOLN.SW
Molecular Partners AG RLF.SW
Relief Therapeutics Holding AG SANN.SW
Santhera Pharmaceuticals Holding AG PPGN.SW
PolyPeptide Group AG VBSN.SW
IVF Hartmann Holding AG ADXN.SW
Addex Therapeutics Ltd DOCM.SW
DocMorris AG
Basilea Pharmaceutica AG IDIA.SW
Idorsia Ltd NWRN.SW
Newron Pharmaceuticals S.p.A. MOLN.SW
Molecular Partners AG RLF.SW
Relief Therapeutics Holding AG SANN.SW
Santhera Pharmaceuticals Holding AG PPGN.SW
PolyPeptide Group AG VBSN.SW
IVF Hartmann Holding AG ADXN.SW
Addex Therapeutics Ltd DOCM.SW
DocMorris AG
Performance
| Periode | BSLN.SW | IDIA.SW | NWRN.SW | MOLN.SW | RLF.SW | SANN.SW | PPGN.SW | VBSN.SW | ADXN.SW | DOCM.SW |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 18.22 % | 254.95 % | 100.00 % | -13.68 % | 10.08 % | -26.82 % | 41.79 % | -12.89 % | 20.72 % | -36.49 % |
| YTD | 16.51 % | 302.45 % | 53.46 % | -35.89 % | -40.45 % | -29.05 % | -19.15 % | -7.67 % | -8.18 % | -68.82 % |
| 1Y | 7.44 % | 228.33 % | 50.89 % | -50.18 % | -57.05 % | 11.89 % | -18.59 % | -1.77 % | -23.48 % | -79.60 % |
| 3Y | 12.18 % | -71.43 % | 905.20 % | -54.85 % | -75.65 % | 71.00 % | -18.00 % | 25.91 % | -56.71 % | -75.80 % |
| 5Y | 0.31 % | -82.99 % | 638.80 % | -82.03 % | -98.69 % | -69.46 % | -62.16 % | -20.40 % | -96.67 % | -97.07 % |
| 10Y | -53.42 % | -71.14 % | -54.71 % | -91.77 % | -86.90 % | -98.95 % | -62.16 % | -14.29 % | -98.08 % | -95.90 % |
| From the beginning | -51.80 % | -71.14 % | -76.69 % | -87.49 % | -99.98 % | -98.87 % | -62.16 % | 1 479.25 % | -99.91 % | -95.90 % |